Nonionic monomers and dimers

European Radiology

Volumn 6, Issue 5, 1996, Pages 756-761

  Stacul, F ^a   Thomsen, H S ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Contrast media; Nonionic dimers; Nonionic monomers

Indexed keywords

CONTRAST MEDIUM;

ANGIOGRAPHY; ANIMAL; CHEMISTRY; ECONOMICS; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; METHODOLOGY; REVIEW;

ANGIOGRAPHY; ANIMALS; CONTRAST MEDIA; HUMANS; INFUSIONS, INTRA-ARTERIAL;

EID: 0030340263     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00187685     Document Type: Review

References (45)

1. Thomsen HS (1994) Universal use of low-osmolar contrast media: a European perspective. Acad Radiol 1: 295
2. Dawson P (1995) Design plays major role in new contrast media. Diagn Imaging Eur June: 3
3. Almén T (1994) The etiology of contrast medium reactions. Invest Radiol 29: S37
4. Moreau JF (1995) Le retrait du Télébrix 38 ou la mémoire de l'iode. J Radiol 76: 9
5. Caille J-M, Leonardi M, Holland I (1995) Contrast selection key to safety of CNS imaging. Diagn Imaging Eur June: 15
6. Sovak M (1985) Introduction: state of the art and design principles of contrast media. In: Sovak M (ed) Handbook of experimental pharmacology, vol 73. Springer, Heidelberg Berlin New York, p 1
7. Thomsen HS, Dorph S, Mygind T, Sovak M, Nielsen H, Rygaard H, Larsen S, Skaarup P, Hemmingsen L, Holm J (1988) Intravenous injection of ioxilan, iohexol and diatrizoate. Effects on urine profiles in the rat. Acta Radiol 29: 131
8. Morris TW (1993) The physiologic effects of nonionic contrast media on the heart. Invest Radiol 28: S45
9. Krause W (1994) Preclinical characterization of iopromide. Invest Radiol 29: S21
10. Rosati G, Davies A, Spinazzi A (1995) Predictable and unpredictable adverse reactions to iomeprol and iopromide. Acad Radiol 3: (in press)
11. Haughton VM, Papke A, Hyland D, Drayer BP, Osborn AG, Maravilla K, Hilal SK (1994) Safety and efficacy of iopromide in cerebral arteriography. Invest Radiol 29: S94
12. Dawson P (1994) Contrast agents in interventional radiology. Adv X-ray Contrast 2: 18
13. Bien S (1995) A non-ionic dimeric contrast agent in cerebral angiography. Eur Radiol 5 (Suppl 2): 45
14. Fischbach R, Landwehr P, Nossen JO, Berg KJ, Eichhorn G, Heindel W, Jacobsen TF (1994) Iodixanol and iopamidol in intravenous DSA. A comparative phase III trial. Cardiovasc Intervent Radiol 17 (Suppl 2): S124
15. Flinck A, Selin K, Bjorneld L (1994) Iodixanol in cardioangiography. Acta Radiol 35 (Suppl 394): S39
16. Gmeinwieser JK, Wenzel-Hora BI (1995) Peripheral and penile angiography with iotrolan 280 versus non-ionic monomers: results of the European clinical phase II and III trials. Eur Radiol 5 (Suppl 2): 30
17. Hagen B, Wenzel-Hora BI (1989) Initial experience with a nonionic, dimeric contrast medium (Iotrolan) in direct and indirect arteriography: a randomized intraindividual double-blind study in 60 patients. In: Taenzer V, Wende S (eds) Recent developments in nonionic contrast media. Thieme, Stuttgart, pp 54-60
18. Hekster REM, Morré HHE, Cleyndert P, Zapletal J, Sinnige LF, Bolstad B, Keetlapper Y (1995) IADSA with isotonic dimeric (Visipaque) and monomeric (Omnipaque) non-ionic contrast media: radiographic, clinical and neurophysiological evaluation. Neuroradiology 37: 48
19. Hori S (1995) A Japanese phase III multicenter comparison of iotrolan 280 with iopamidol 300 in peripheral arteriography. Eur Radiol 5 (Suppl 2): 24
20. Kendall BE, Sheppick A, Nossen JO, Stevens J (1995) Iodixanol in intraarterial cerebral digital subtraction angiography: a comparison with iohexol (Omnipaque). Neuroradiology (in press)
21. Manninen M, Tahvanainen K, Borch KW, Wallén T, Soimakallio S, Matsi P, Suhonen M (1995) Iodixanol, a new non-ionic dimeric contrast medium in cardioangiography: a double-masked parallel comparison with iopromide. Eur Radiol 5: 364
22. Singh K, Sundgren R, Bolstad B, Bjork L, Lie M (1993) Iodixanol in abdominal digital subtraction angiography. A randomized, double-blind, parallel trial with iodixanol and iohexol. Acta Radiol 34: 242
23. Sumie H, Katayama H (1995) Iotrolan in cerebral angiography. A Japanese phase III multicenter comparative study with iopamidol. Eur Radiol 5 (Suppl 2): 39
24. Thorstensen O, Albrechtsson U, Calissendorff B, Larusdottir H, Norgren L, Tengvar M, Bolstad B, Aspelin P (1994) Iodixanol in femoral arteriography. A randomized, double-blind, phase III, parallel study with iodixanol 270 mgI/ml and iohexol 300 mgI/ml. Acta Radiol 35: 629
25. Verow P, Nossen JO, Sheppick A, Kjaersgaard P (1995) Isotonic contrast medium in aorto-femoral angiography. Dimeric iodixanol is a good alternative to iopamidol. Br J Radiol (in press)
26. Klow NE, Levorstad K, Berg KJ, Brodahl U, Endressen K, Kristoffersen DT, Laake B, Simonsen S, Tofte AJ, Lundby B (1993) Iodixanol in cardioangiography in patients with coronary artery disease Acta Radiol 34: 72
27. Taenzer V, Wenzel-Hora B (1989) Urography with monomeric and dimeric nonionic contrast media: comparative, randomized, double-blind study of Iotrolan 280 and Iopromide 300. In: Taenzer V, Wende S (eds) Recent developments in nonionic contrast media. Thieme, Stuttgart, pp 116-118
28. Adolph JMG, Engelkamp H, Herbig W, Peters PE, Wenzel-Hora BI (1995) Iotrolan in urography: efficacy and tolerance in comparison with iohexol and iopamidol. Eur Radiol 5 (Suppl 2): 63
29. Narimatsu Y, Hiramatsu K (1995) A Japanese multicenter comparison of iotrolan 280 with iopamidol 300 in intravenous urography. Eur Radiol 5 (Suppl 2): 58
30. Troeger J, Wenzel-Hora BI, Darge K (1995) Iotrolan in pediatric examinations. Eur Radiol 5 (Suppl 2): 69
31. Conroy RM, Bjartveit K, Sheppick A, Long U, Masteron J (1994) Iodixanol in intravenous urography: a comparison of iodixanol 270 mg I/ml, iodixanol 320 mg I/ml and iopamidol 300 mg I/ml (Niopam). Clin Radiol 49: 337
32. Sundgren PC, Baath L, Törnquist C, Grynne BH, Almén T. Diagnostic efficacy and safety of iodixanol 320 mg I/ml vs iohexol 350 mm I/ml in intravenous urography. (submitted)
33. Saxton HM (1989) Opacification of collecting ducts at urography. Radiology 170: 16
34. Bruenger C (1995) Clinical safety of iotrolan 280: the Japanese experience. Eur Radiol 5 (Suppl 2): 89
35. Silvay-Mandeau OM, Meissner C, Wenzel-Hora BI (1995) Clinical safety assessment of iotrolan 280 in European clinical trials. Eur Radiol 5 (Suppl 2): 85
36. Andreula C, Carella A, Colombo MM, DeBlasi RM, Klaveness AJ, Mazza A, Simionato F, Scotti G (1993) Valutazione della sicurezza ed efficacia di iodixanolo 270 mg I/ml e 320 mg I/ml a confronto con iopamidolo 300 mg I/ml nella TC cerebrale. Riv Neuroradiol 6: 397
37. Pugh PD, Sissons GRJ, Ruttley MST, Berg KJ, Nossen JO, Eide H (1993) Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide. Invest Radiol 17: 70
38. Morris TW, Kem MA, Katzberg RW (1982) The effects of media viscosity on hemodynamics in selective arteriography. Invest Radiol 17: 70
39. Ueda J, Nygren A, Hansell P, Ulfendahl HR (1993) Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiol 34: 83
40. Clauss W, Dinger J, Meissner C (1995) Renal tolerance of iotrolan 280 - a meta-analysis of 14 double-blind studies. Eur Radiol 5 (Suppl 2): 79
41. Langer M, Langer R, Zwicker C, Speck U, Jaenicke UA, Felix R (1991) Clinical and nephrologic tolerance of iopromide and iotrolan in computed tomography. Invest Radiol 26 (Suppl 1): S83
42. Jakobsen JA, Berg KJ, Nossen JO (1994) Renal function and contrast retention after angiography in patients with severe renal failure. Acta Radiol 35 (Suppl 394): S38
43. Wilcox J, Sage MR (1984) Is viscosity important in the production of blood-brain barrier disruption by intracarotid contrast media? Neuroradiology 26: 511
44. Michelet AA (1987) Effects of intravascular contrast media on blood-brain barrier. Acta Radiol 28: 329
45. Grynne BH, Nossen JO, Bolstad B, Borch KW. Main results of the first comparative clinical studies on Visipaque. (submitted)